The societal costs of Cystic Fibrosis in Switzerland
Description
This study on the societal costs of cystic fibrosis (CF) in Switzerland aimed to estimate the different dimensions of CF disease burden, which are not generated by direct medical costs. CF has a high morbidity and mortality, as a consequence there is loss of quality of life as well as years of life. We thus conducted an online survey for the patients with CF and their carers to allow us to estimate this societal burden of CF.
Key data
Projectlead
Dr. Renato Mattli
Deputy Projectlead
Project team
Johannes Pöhlmann, Dr. Christina Vetsch-Tzogiou
Project status
completed, 04/2019 - 12/2020
Institute/Centre
Winterthur Institute of Health Economics (WIG)
Funding partner
Other